fda warning bpc 157 safety cancer issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of BPC-157 FDA Approval Status: Is
Description
Features investigated in recorded photographs included the hemorrhagic lesions in the stomach assessed as the sum of the longest lesion diameters after isoprenaline administration and following medication at 30 min
This product must be handled in compliance with applicable US federal and state regulations and standard laboratory safety guidelines
A study from Binder et al
I could not find the ingredients (other than the photo provided that is not legible), so I have posted a picture with my review
The GLP-1 era represents a genuine step change in what medicine can achieve for people with obesity
A Systematic Review." American Journal of Gastroenterology
